new glp 1 medications Decoding GLP-1 Weight Loss Professor Receives Grant to Study

Drucker & team identify the vascular smooth muscle GLP-1 receptor as a key cellular target for the actions of GLP-1 medicines to lower blood pressure

Cognitive decline Research has begun to elucidate the adverse impact of T2DM on cognitive function in PD

Currently, medications for obesity alone are not covered under Medicare

Patients with specific genetic profiles may experience more pronounced effects on cognitive symptoms, while others may notice primarily metabolic changes

Fiber fermentation drives butyrate production Dietary fiber is the primary fuel for butyrate-producing bacteria in the colon

Similarly, in male rats with type II diabetes, administration of liraglutide selectively promoted the enrichment of short-chain fatty acid (SCFA)-producing taxa, including Bacteroides , Lachnospiraceae, and other beneficial probiotic species